ACON is an international consortium, focused on studying diagnosis and treatment of subjects with a first-ever optic neuritis. The broad enrolment of patients of all ethnicities and from all continents ensures an excellent representation of the heterogeneity of this condition. Many of the enrolled patients will then be diagnosed with NMOSD, MOGAD or MS and are eligible for preventive immunotherapy.
The ACON offers an expert Treatment Day giving an overview over acute and long-term treatment Options in neuroimmunological diseases.